__timestamp | Jazz Pharmaceuticals plc | Wave Life Sciences Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 117418000 | 2395000 |
Thursday, January 1, 2015 | 102526000 | 9057000 |
Friday, January 1, 2016 | 105386000 | 393000 |
Sunday, January 1, 2017 | 110188000 | 79309000 |
Monday, January 1, 2018 | 121544000 | 134428000 |
Tuesday, January 1, 2019 | 127930000 | 175431000 |
Wednesday, January 1, 2020 | 148917000 | 124165000 |
Friday, January 1, 2021 | 440760000 | 121875000 |
Saturday, January 1, 2022 | 540517000 | 10114000 |
Sunday, January 1, 2023 | 435577000 | 9206000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding cost structures is pivotal. Jazz Pharmaceuticals plc and Wave Life Sciences Ltd. offer a fascinating study in contrasts. From 2014 to 2023, Jazz Pharmaceuticals saw a staggering 370% increase in its cost of revenue, peaking in 2022. This surge reflects its aggressive expansion and investment in innovative therapies. Meanwhile, Wave Life Sciences, though smaller, experienced a dramatic 7,300% rise in costs from 2014 to 2019, highlighting its rapid R&D advancements. However, post-2019, Wave's costs stabilized, indicating a strategic shift towards efficiency. This decade-long analysis underscores the diverse strategies of these biotech players, with Jazz focusing on scaling operations and Wave honing its research capabilities. As the industry braces for future challenges, these insights provide a window into the financial maneuvers shaping the future of pharmaceuticals.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Alkermes plc
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.